ZA963716B - A process for the preparation of lercanidipine hydrochloride - Google Patents
A process for the preparation of lercanidipine hydrochlorideInfo
- Publication number
- ZA963716B ZA963716B ZA963716A ZA963716A ZA963716B ZA 963716 B ZA963716 B ZA 963716B ZA 963716 A ZA963716 A ZA 963716A ZA 963716 A ZA963716 A ZA 963716A ZA 963716 B ZA963716 B ZA 963716B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- lercanidipine hydrochloride
- lercanidipine
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI950957A IT1274480B (it) | 1995-05-12 | 1995-05-12 | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA963716B true ZA963716B (en) | 1996-11-20 |
Family
ID=11371581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA963716A ZA963716B (en) | 1995-05-12 | 1996-05-10 | A process for the preparation of lercanidipine hydrochloride |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP0824517B1 (zh) |
| JP (1) | JP4038622B2 (zh) |
| KR (1) | KR100395441B1 (zh) |
| CN (1) | CN1101810C (zh) |
| AR (1) | AR002739A1 (zh) |
| AT (1) | ATE221050T1 (zh) |
| AU (1) | AU694046B2 (zh) |
| BG (1) | BG62400B1 (zh) |
| BR (1) | BR9608374A (zh) |
| CA (1) | CA2217849C (zh) |
| CZ (1) | CZ288634B6 (zh) |
| DE (1) | DE69622552T2 (zh) |
| DK (1) | DK0824517T3 (zh) |
| DZ (1) | DZ2032A1 (zh) |
| EA (1) | EA000346B1 (zh) |
| EE (1) | EE03351B1 (zh) |
| EG (1) | EG21755A (zh) |
| ES (1) | ES2179942T3 (zh) |
| HU (1) | HU226709B1 (zh) |
| IL (1) | IL118143A (zh) |
| IN (1) | IN188486B (zh) |
| IT (1) | IT1274480B (zh) |
| MA (1) | MA23858A1 (zh) |
| MX (1) | MX9708662A (zh) |
| MY (1) | MY113802A (zh) |
| NO (1) | NO309423B1 (zh) |
| NZ (1) | NZ309059A (zh) |
| PL (1) | PL185260B1 (zh) |
| PT (1) | PT824517E (zh) |
| RO (1) | RO119616B1 (zh) |
| SA (1) | SA96170216B1 (zh) |
| SK (1) | SK283321B6 (zh) |
| TN (1) | TNSN96069A1 (zh) |
| TW (1) | TW404940B (zh) |
| UA (1) | UA46769C2 (zh) |
| WO (1) | WO1996035668A1 (zh) |
| ZA (1) | ZA963716B (zh) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| EP1553941A1 (en) * | 2002-10-16 | 2005-07-20 | Recordati Ireland Limited | Lisinopril/lercanidipine combination therapy |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR100713136B1 (ko) * | 2005-05-04 | 2007-05-02 | 주식회사 대희화학 | 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법 |
| DE602005017199D1 (de) | 2005-06-15 | 2009-11-26 | Hetero Drugs Ltd | Neues verfahren zur herstellung von lercanidipin |
| US8097729B2 (en) | 2005-09-16 | 2012-01-17 | Glenmark Generics Ltd. | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
| KR100811497B1 (ko) * | 2005-10-19 | 2008-03-07 | 신풍제약주식회사 | 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법 |
| DE602006003877D1 (de) * | 2006-05-24 | 2009-01-08 | Cf Pharma Ltd | Verfahren zur Herstellung von Lercanipidin |
| KR100808281B1 (ko) * | 2006-06-30 | 2008-03-03 | 주식회사 하원정밀화학 | 레르카니디핀 및 그 산부가염의 제조방법 |
| CN102020602B (zh) * | 2009-09-18 | 2013-12-25 | 深圳信立泰药业股份有限公司 | 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物 |
| WO2011161223A2 (en) | 2010-06-23 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| SI2654729T1 (sl) | 2010-12-24 | 2016-08-31 | Krka, D.D., Novo Mesto | Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino |
| CN102516160B (zh) * | 2011-12-16 | 2014-04-02 | 华润赛科药业有限责任公司 | 一种高纯盐酸乐卡地平的合成工艺 |
| CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
| CN102584682A (zh) * | 2011-12-31 | 2012-07-18 | 苏州二叶制药有限公司 | 盐酸乐卡地平的制备方法 |
| CN109956943B (zh) * | 2019-04-18 | 2021-07-20 | 合肥合源药业有限公司 | 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-05-12 IT ITMI950957A patent/IT1274480B/it active IP Right Grant
-
1996
- 1996-05-03 IL IL11814396A patent/IL118143A/en not_active IP Right Cessation
- 1996-05-06 IN IN822CA1996 patent/IN188486B/en unknown
- 1996-05-07 MA MA24223A patent/MA23858A1/fr unknown
- 1996-05-08 DZ DZ960075A patent/DZ2032A1/fr active
- 1996-05-09 ES ES96916111T patent/ES2179942T3/es not_active Expired - Lifetime
- 1996-05-09 CA CA002217849A patent/CA2217849C/en not_active Expired - Lifetime
- 1996-05-09 WO PCT/EP1996/002122 patent/WO1996035668A1/en active IP Right Grant
- 1996-05-09 PT PT96916111T patent/PT824517E/pt unknown
- 1996-05-09 EG EG40296A patent/EG21755A/xx active
- 1996-05-09 EA EA199700374A patent/EA000346B1/ru not_active IP Right Cessation
- 1996-05-09 AU AU58985/96A patent/AU694046B2/en not_active Expired
- 1996-05-09 KR KR1019970707905A patent/KR100395441B1/ko not_active IP Right Cessation
- 1996-05-09 PL PL96323236A patent/PL185260B1/pl unknown
- 1996-05-09 NZ NZ309059A patent/NZ309059A/xx not_active IP Right Cessation
- 1996-05-09 CZ CZ19973567A patent/CZ288634B6/cs not_active IP Right Cessation
- 1996-05-09 JP JP53379796A patent/JP4038622B2/ja not_active Expired - Lifetime
- 1996-05-09 RO RO97-02101A patent/RO119616B1/ro unknown
- 1996-05-09 EP EP96916111A patent/EP0824517B1/en not_active Expired - Lifetime
- 1996-05-09 UA UA97125981A patent/UA46769C2/uk unknown
- 1996-05-09 BR BR9608374A patent/BR9608374A/pt not_active Application Discontinuation
- 1996-05-09 MY MYPI96001751A patent/MY113802A/en unknown
- 1996-05-09 CN CN96193842A patent/CN1101810C/zh not_active Expired - Lifetime
- 1996-05-09 HU HU9801913A patent/HU226709B1/hu unknown
- 1996-05-09 DE DE69622552T patent/DE69622552T2/de not_active Expired - Lifetime
- 1996-05-09 EE EE9700303A patent/EE03351B1/xx unknown
- 1996-05-09 SK SK1514-97A patent/SK283321B6/sk not_active IP Right Cessation
- 1996-05-09 AT AT96916111T patent/ATE221050T1/de active
- 1996-05-09 DK DK96916111T patent/DK0824517T3/da active
- 1996-05-10 TW TW085105567A patent/TW404940B/zh not_active IP Right Cessation
- 1996-05-10 AR ARP960102528A patent/AR002739A1/es unknown
- 1996-05-10 ZA ZA963716A patent/ZA963716B/xx unknown
- 1996-05-10 TN TNTNSN96069A patent/TNSN96069A1/fr unknown
- 1996-08-07 SA SA96170216A patent/SA96170216B1/ar unknown
-
1997
- 1997-11-07 BG BG102034A patent/BG62400B1/bg unknown
- 1997-11-11 NO NO975176A patent/NO309423B1/no not_active IP Right Cessation
- 1997-11-11 MX MX9708662A patent/MX9708662A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117188A0 (en) | Process for the preparation of thietanones | |
| HUP9901085A3 (en) | A process for preparing aza-cyclohexapeptide derivatives | |
| HUP9602957A3 (en) | Process for the preparation of dihalo-azolopyrimidines | |
| NZ309059A (en) | A process for the preparation of lercanidipine hydrochloride | |
| HK1028619A1 (en) | Process for the preparation of a polyamide-polyurethane micro-blend | |
| GB2303717B (en) | Process for positioning a part | |
| GB9512546D0 (en) | A process for the preparation of esters | |
| GB9317491D0 (en) | New compound and a process for preparation thereof | |
| HUP9901261A3 (en) | Process for the manufacture of a colour-marked object | |
| IL115090A0 (en) | Process for the preparation of p-bromofluorobenzene | |
| SI0824517T1 (en) | A process for the preparation of lercanidipine hydrochloride | |
| GB2305915B (en) | Process for the preparation of 2-chloro-4-methylphenol | |
| ZA968604B (en) | A process for the preparation of alpha-chloromethylphenyl-acetic acid derivatives | |
| AU4878897A (en) | Process for the preparation of a pharmaceutical intermediate | |
| IL118732A (en) | Process for the preparation of arylidene-substituted alkylcycloalkanones | |
| ZA959751B (en) | A process for the preparation of isocyanates | |
| IL118817A0 (en) | A process for the preparation of octyl P-methoxy cinnamate | |
| GB9525073D0 (en) | A process | |
| AU3850597A (en) | A process for the preparation of dihydropyridines | |
| IL117834A0 (en) | Process for the preparation of a steroid | |
| ZA961345B (en) | Process for the preparation of theitane amines | |
| AU3699895A (en) | Process for the preparation of a thiazoline-azetidinone | |
| IL121253A0 (en) | A process for the preparation of para-fluorophenol | |
| EP0738707A3 (en) | Dianilinoglutacondialdehyde compounds and process for their preparation | |
| GB9610655D0 (en) | Process for the preparation of a B3-agonist |